Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3632972 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL1848576 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL31480060 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Fluoride SCHEMBL11696786 | 0.96 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL11652942 | 0.96 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL673791 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL1855223 | 0.96 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| SCHEMBL1230668 | 0.96 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL150721 | 0.96 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL1850499 | 0.96 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637541-B2 | Alkylene oxide polymerization using aluminum compounds and cyclic amidines | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-05-26 | — | — | US | disclosed |
| CN-115996830-B | Flexible tube for endoscope, endoscopic medical device, and method for producing same | 富士胶片株式会社 | 2025-05-13 | — | — | CN | disclosed |
| US-20230095201-A1 | ALKYLENE OXIDE POLYMERIZATION USING ALUMINUM COMPOUNDS AND CYCLIC AMIDINES | DOW GLOBAL TECHNOLOGIES LLC | 2023-03-30 | — | — | US | disclosed |
| CN-110204434-B | Copper ion guiding aluminum-based metal-organic framework material, and preparation method and application thereof | 扬州大学 | 2022-02-11 | — | — | CN | disclosed |
| WO-2007094559-A1 | GETTER FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | DOOSAN CORPORATION (KR) | 2007-08-23 | — | — | WO | disclosed |
| EP-1765748-A1 | PROCESS FOR PREPARING LINEAR ALPHA OLEFINS | Shell Internationale Research Maatschappij B.V. (NL) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006119540-A1 | PREPARATION FOR TREATING PSORIASIS | NICOLOPOULOS JENNY (AU) | 2006-11-16 | — | — | WO | disclosed |
| WO-2006005762-A1 | PROCESS FOR PREPARING LINEAR ALPHA OLEFINS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2006-01-19 | — | — | WO | disclosed |
| US-4617360-A | SOLID CATALYST COMPLEX FROM OXYGEN-CONTAINING MAGNESIUM COMPOUNDS, OXYGEN-CONTAINING TITANUIM COMPOUNDS AND ORGANOALUMINUM HALIDE COMPOUNDS | SOLVAY & CIE. (BE) | 1986-10-14 | — | — | US | disclosed |
| EP-0000007-B1 | PROCESS FOR THE POLYMERISATION OF ALPHA-OLEFINS AND METHOD FOR PREPARING SOLID CATALYTIC COMPLEXES FOR USE IN THIS POLYMERISATION PROCESS | SOLVAY & Cie (Société Anonyme) (BE) | 1981-05-20 | — | — | EP | disclosed |
| EP-0000007-A1 | Process for the polymerisation of alpha-olefins and method for preparing solid catalytic complexes for use in this polymerisation process | SOLVAY & Cie (Société Anonyme) (BE) | 1978-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637541-B2 | Alkylene oxide polymerization using aluminum compounds and cyclic amidines | MLST8, PFAS, SQLE | TSHR 2507/4885THRB 2526/4885DNM1 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.